SallyGTamayoMD

PubMed

• 39 citations
  Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers.
  Tamayo Sg, Leland S. Rickman, William C. Mathews, Steven C. Fullerton, Bartok Ae, Warner Jt, David W. Feigal, Arnstein Dg, Callandar Ns, Lyche Kd> ;Journal of General Internal Medicine. 1993 Feb 1
• 3 citations
  Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics.
  Arlene Tave, Earl L. Goehring, Vibha C. A. Desai, Chuntao Wu, Rhonda L. Bohn, Sally Tamayo, Nicholas Sicignano, Juhaeri Juhaeri, Judith K. Jones, Sheila R. Weiss> ;Pharmacoepidemiology and Drug Safety. 2021 Mar 17
• Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation
  Manesh R. Patel, W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen Hopf, Zhong Yuan> ;Clinical and Experimental Emergency Medicine. 2018 Mar 30
• 12 citations
  Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
  A. John Camm, Craig I Coleman, Torben Larsen, Peter Brønnum Nielsen, Capt Sally Tamayo> ;Thrombosis and Haemostasis. 2018 Mar 22
• 3 citations
  Successful treatment of community-acquired methicillin-resistant Staphylococcus aureus purulent myopericarditis.
  Henry DeYoung, Adam S. Bloom, Sally Tamayo> ;BMJ Case Reports. 2017 Oct 10
• 4 citations
  A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban.
  Louis M. Kwong, Alexander G.G. Turpie, Sally Tamayo, W. Frank Peacock, Zhong Yuan, Nicholas Sicignano, Kathleen Hopf, Manesh R. Patel> ;Current Medical Research and Opinion. 2017 Jul 20
• 9 citations
  CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban.
  W. Frank Peacock, Sally Tamayo, Manesh R. Patel, Nicholas Sicignano, Kathleen Hopf, Zhong Yuan> ;Annals of Emergency Medicine. 2017 May 1
• 11 citations
  Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
  W. Frank Peacock, Sally Tamayo, Nicholas Sicignano, Kathleen Hopf, Zhong Yuan, Manesh R. Patel> ;The American Journal of Cardiology. 2017 Mar 1
• 34 citations
  Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice
  Jan Beyer-Westendorf, A. J. Camm, Craig I Coleman, S. Tamayo> ;Thrombosis and Haemostasis. 2016 Sep 14
• 4 citations
  Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
  Sally Tamayo, Jason C. Simeone, Beth L. Nordstrom, Manesh R. Patel, Zhong Yuan, Nicholas Sicignano, W. Frank Peacock> ;Journal of the American College of Cardiology. 2016 Sep 6
• 121 citations
  Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban
  Sally Tamayo, W. Frank Peacock, Manesh R. Patel, Nicholas Sicignano, Kathleen Hopf, Larry E. Fields, Troy C. Sarich, Shujian Wu, Daniel Yannicelli, Zhong Yuan> ;Clinical Cardiology. 2015 Feb 1
• Join now to see all